LPL Financial LLC lowered its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 12.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,342 shares of the company's stock after selling 1,325 shares during the period. LPL Financial LLC owned approximately 0.06% of Chemed worth $4,949,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of CHE. UMB Bank n.a. boosted its position in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Atala Financial Inc purchased a new position in Chemed during the fourth quarter valued at $29,000. CBIZ Investment Advisory Services LLC raised its stake in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares during the last quarter. Trust Co. of Vermont bought a new stake in Chemed in the fourth quarter worth $34,000. Finally, Tortoise Investment Management LLC grew its stake in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after acquiring an additional 34 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.
Chemed Trading Up 0.2 %
CHE stock traded up $1.05 during midday trading on Friday, hitting $591.44. The company's stock had a trading volume of 104,450 shares, compared to its average volume of 97,296. The firm's 50-day moving average is $583.16 and its 200-day moving average is $567.72. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $625.09. The company has a market cap of $8.64 billion, a PE ratio of 29.89, a P/E/G ratio of 2.15 and a beta of 0.49.
Chemed Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is currently 10.05%.
Insider Activity at Chemed
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.32% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on CHE shares. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada raised their price objective on shares of Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research note on Friday, March 14th.
Check Out Our Latest Research Report on Chemed
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.